SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BBTX

Bambusa Therapeutics, Inc. (NASDAQ:BBTX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
16.00+1.01 (+6.74%)
 
Market cap
$796M
Insider Score
Listed since
Oct 30, 2026
Insider Score
84/ 100
BBTX Insider Score
Bullish

1 qualifying trade · 1 insider · $12.00M bought in the last 90 days

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

BBTX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New BBTX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BBTX from public contracts

Source: USAspending.gov

Recently reported changes in BBTX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing BBTX, reported under the STOCK Act.

PoliticianChamberActionAmountDate
No congressional trades recorded for BBTX.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Bambusa Therapeutics, Inc. (BBTX) Government Contracts & Lobbying | InsiderBuying.com